{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:51:23Z","timestamp":1791582683977,"version":"4.3.4"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00210-026-05661-7","type":"journal-article","created":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T01:51:26Z","timestamp":1782957086000},"page":"19991-20008","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Investigation of the cytotoxic and apoptotic effects of propylthiouracil-loaded mesoporous nanoparticles on Ehrlich ascites tumor cells"],"prefix":"10.1007","volume":"399","author":[{"given":"Hatice Nur","family":"\u015eeflek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9305-4782","authenticated-orcid":false,"given":"Fatma Zehra","family":"Erbayram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emre Burak","family":"Ertu\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif G\u00fclbah\u00e7e","family":"Mutlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015eerife","family":"Alpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma Nur","family":"T\u00fcrko\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"5661_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2019.109922","volume":"104","author":"M Abedi","year":"2019","unstructured":"Abedi M, Abolmaali SS, Abedanzadeh M, Borandeh S, Samani SM, Tamaddon AM (2019) Citric acid functionalized silane coupling versus post-grafting strategy for dual pH and saline responsive delivery of cisplatin by Fe3O4\/carboxyl functionalized mesoporous SiO2 hybrid nanoparticles: a-synthesis, physicochemical and biological characterization. Mater Sci Eng C Mater Biol Appl 104:109922. https:\/\/doi.org\/10.1016\/j.msec.2019.109922","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"4","key":"5661_CR2","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1021\/mp800051m","volume":"5","author":"F Alexis","year":"2008","unstructured":"Alexis F, Pridgen E, Langer R, Farokhzad OC (2008) Nanoparticle technologies for cancer therapy. Mol Pharm 5(4):505\u2013515","journal-title":"Mol Pharm"},{"issue":"1","key":"5661_CR3","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1007\/s00210-025-04318-1","volume":"399","author":"F Alsaikhan","year":"2026","unstructured":"Alsaikhan F (2026) The synergistic effect of resveratrol and curcumin on oncogenic lncRNA MAPT-IT1 and ferroptosis-related genes in breast cancer. Naunyn Schmiedebergs Arch Pharmacol 399(1):1091\u20131108. https:\/\/doi.org\/10.1007\/s00210-025-04318-1","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"Pt 3","key":"5661_CR4","doi-asserted-by":"publisher","first-page":"135893","DOI":"10.1016\/j.ijbiomac.2024.135893","volume":"280","author":"F Alsaikhan","year":"2024","unstructured":"Alsaikhan F, Farhood B (2024) Recent advances on chitosan\/hyaluronic acid-based stimuli-responsive hydrogels and composites for cancer treatment: a comprehensive review. Int J Biol Macromol 280(Pt 3):135893. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.135893. (Advance online publication)","journal-title":"Int J Biol Macromol"},{"issue":"8","key":"5661_CR5","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrd1468","volume":"3","author":"TT Ashburn","year":"2004","unstructured":"Ashburn TT, Thor KB (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 3(8):673\u2013683. https:\/\/doi.org\/10.1038\/nrd1468","journal-title":"Nat Rev Drug Discov"},{"issue":"19","key":"5661_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201704307","volume":"30","author":"J Bourquin","year":"2018","unstructured":"Bourquin J, Milosevic A, Hauser D, Lehner R, Blank F, Petri-Fink A, Rothen-Rutishauser B (2018) Biodistribution, clearance, and long-term fate of clinically relevant nanomaterials. Adv Mater (Deerfield Beach, Fla) 30(19):e1704307. https:\/\/doi.org\/10.1002\/adma.201704307","journal-title":"Adv Mater (Deerfield Beach, Fla)"},{"issue":"14","key":"5661_CR7","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1016\/j.biomaterials.2013.01.084","volume":"34","author":"R Cheng","year":"2013","unstructured":"Cheng R, Meng F, Deng C, Klok HA, Zhong Z (2013) Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery. Biomaterials 34(14):3647\u20133657. https:\/\/doi.org\/10.1016\/j.biomaterials.2013.01.084","journal-title":"Biomaterials"},{"key":"5661_CR8","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jconrel.2019.06.028","volume":"307","author":"TJ Dening","year":"2019","unstructured":"Dening TJ, Zemlyanov D, Taylor LS (2019) Application of an adsorption isotherm to explain incomplete drug release from ordered mesoporous silica materials under supersaturating conditions. J Control Release 307:186\u2013199. https:\/\/doi.org\/10.1016\/j.jconrel.2019.06.028","journal-title":"J Control Release"},{"issue":"23","key":"5661_CR9","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMra1204479","volume":"366","author":"VT DeVita Jr","year":"2012","unstructured":"DeVita VT Jr, Rosenberg SA (2012) Two hundred years of cancer research. N Engl J Med 366(23):2207\u20132214. https:\/\/doi.org\/10.1056\/NEJMra1204479","journal-title":"N Engl J Med"},{"issue":"12","key":"5661_CR10","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nrc.2017.93","volume":"17","author":"MW Dewhirst","year":"2017","unstructured":"Dewhirst MW, Secomb TW (2017) Transport of drugs from blood vessels to tumour tissue. Nat Rev Cancer 17(12):738\u2013750. https:\/\/doi.org\/10.1038\/nrc.2017.93","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"5661_CR11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.bbrc.2017.06.190","volume":"500","author":"F Edlich","year":"2018","unstructured":"Edlich F (2018) BCL-2 proteins and apoptosis: recent insights and unknowns. Biochem Biophys Res Commun 500(1):26\u201334. https:\/\/doi.org\/10.1016\/j.bbrc.2017.06.190","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"5661_CR12","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/sj.onc.1210666","volume":"27","author":"H Ehrhardt","year":"2008","unstructured":"Ehrhardt H, H\u00e4cker S, Wittmann S, Maurer M, Borkhardt A, Toloczko A, Debatin KM, Fulda S, Jeremias I (2008) Cytotoxic drug-induced, p53-mediated upregulation of caspase-8 in tumor cells. Oncogene 27(6):783\u2013793. https:\/\/doi.org\/10.1038\/sj.onc.1210666","journal-title":"Oncogene"},{"key":"5661_CR13","first-page":"871","volume":"28","author":"P Ehrlich","year":"1905","unstructured":"Ehrlich P, Apolant H (1905) Beobachtungen Uber MaligneMausentumoren Berlin KlinWshr 28:871\u2013874","journal-title":"Beobachtungen Uber MaligneMausentumoren Berlin KlinWshr"},{"key":"5661_CR14","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/354445a0","volume":"354","author":"SR Elliott","year":"1991","unstructured":"Elliott SR (1991) Medium-range structural order in covalent amorphous solids. Nature 354:445\u2013452. https:\/\/doi.org\/10.1038\/354445a0","journal-title":"Nature"},{"key":"5661_CR15","doi-asserted-by":"publisher","DOI":"10.7324\/JAPS.2024.168308","author":"EB Ertus","year":"2024","unstructured":"Ertus EB, Gulbahce-Mutlu E, Alpa S, Ozturk A (2024) Production and biological properties of nano porous glass microparticles for anticancer drug carrier. J Appl Pharm Sci. https:\/\/doi.org\/10.7324\/JAPS.2024.168308","journal-title":"J Appl Pharm Sci"},{"issue":"9","key":"5661_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/nano11092222","volume":"11","author":"M Gisbert-Garzar\u00e1n","year":"2021","unstructured":"Gisbert-Garzar\u00e1n M, Vallet-Reg\u00ed M (2021) Redox-responsive mesoporous silica nanoparticles for cancer treatment: recent updates. Nanomaterials (Basel, Switzerland) 11(9):2222. https:\/\/doi.org\/10.3390\/nano11092222","journal-title":"Nanomaterials (Basel, Switzerland)"},{"issue":"6","key":"5661_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13061292","volume":"13","author":"S Hafezi","year":"2021","unstructured":"Hafezi S, Rahmani M (2021) Targeting BCL-2 in cancer: advances, challenges, and perspectives. Cancers 13(6):1292. https:\/\/doi.org\/10.3390\/cancers13061292","journal-title":"Cancers"},{"issue":"5","key":"5661_CR18","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"issue":"1","key":"5661_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5681\/apb.2015.001","volume":"5","author":"R Heidari","year":"2015","unstructured":"Heidari R, Niknahad H, Jamshidzadeh A, Eghbal MA, Abdoli N (2015) An overview on the proposed mechanisms of antithyroid drugs-induced liver injury. Adv Pharm Bull 5(1):1\u201311. https:\/\/doi.org\/10.5681\/apb.2015.001","journal-title":"Adv Pharm Bull"},{"issue":"10","key":"5661_CR20","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/nrc1456","volume":"4","author":"CH Heldin","year":"2004","unstructured":"Heldin CH, Rubin K, Pietras K, Ostman A (2004) High interstitial fluid pressure - an obstacle in cancer therapy. Nat Rev Cancer 4(10):806\u2013813. https:\/\/doi.org\/10.1038\/nrc1456","journal-title":"Nat Rev Cancer"},{"issue":"1B","key":"5661_CR21","first-page":"617","volume":"23","author":"AA Hercbergs","year":"2003","unstructured":"Hercbergs AA, Goyal LK, Suh JH, Lee S, Reddy CA, Cohen BH, Stevens GH, Reddy SK, Peereboom DM, Elson PJ, Gupta MK, Barnett GH (2003) Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a phase I\/II study. Anticancer Res 23(1B):617\u2013626","journal-title":"Anticancer Res"},{"issue":"12","key":"5661_CR22","first-page":"3039","volume":"47","author":"RK Jain","year":"1987","unstructured":"Jain RK (1987) Transport of molecules in the tumor interstitium: a review. Cancer Res 47(12):3039\u20133051","journal-title":"Cancer Res"},{"issue":"11","key":"5661_CR23","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nrclinonc.2010.139","volume":"7","author":"RK Jain","year":"2010","unstructured":"Jain RK, Stylianopoulos T (2010) Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 7(11):653\u2013664. https:\/\/doi.org\/10.1038\/nrclinonc.2010.139","journal-title":"Nat Rev Clin Oncol"},{"issue":"15","key":"5661_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ma18153597","volume":"18","author":"A Karczmarska","year":"2025","unstructured":"Karczmarska A, Laskowska W, Str\u00f3\u017c D, Pawlik K (2025) Inside the framework: structural exploration of mesoporous silicas MCM-41, SBA-15, and SBA-16. Materials (Basel) 18(15):3597. https:\/\/doi.org\/10.3390\/ma18153597","journal-title":"Materials (Basel)"},{"key":"5661_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00059","volume":"10","author":"E Krashin","year":"2019","unstructured":"Krashin E, Piekie\u0142ko-Witkowska A, Ellis M, Ashur-Fabian O (2019) Thyroid hormones and cancer: a comprehensive review of preclinical and clinical studies. Front Endocrinol 10:59. https:\/\/doi.org\/10.3389\/fendo.2019.00059","journal-title":"Front Endocrinol"},{"key":"5661_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0927-7757(01)00638-0","volume":"187\u2013188","author":"D Kumar","year":"2001","unstructured":"Kumar D, Schumacher K, du Fresne von Hohenesche C, Gr\u00fcn M, Unger KK (2001) MCM-41, MCM-48 and related mesoporous adsorbents: their synthesis and characterisation. Colloids Surf A Physicochem Eng Asp 187\u2013188:109\u2013116. https:\/\/doi.org\/10.1016\/S0927-7757(01)00638-0","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"issue":"1","key":"5661_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/BF02255913","volume":"7","author":"HC Lee","year":"2000","unstructured":"Lee HC, Wei YH (2000) Mitochondrial role in life and death of the cell. J Biomed Sci 7(1):2\u201315. https:\/\/doi.org\/10.1007\/BF02255913","journal-title":"J Biomed Sci"},{"issue":"45","key":"5661_CR28","doi-asserted-by":"publisher","first-page":"61787","DOI":"10.1021\/acsami.4c16609","volume":"16","author":"YT Lee","year":"2024","unstructured":"Lee YT, Wu SH, Wu CH, Lin YH, Lin CK, Chen ZA, Sun TC, Chen YJ, Chen P, Mou CY, Chen YP (2024) Drug-free mesoporous silica nanoparticles enable suppression of cancer metastasis and confer survival advantages to mice with tumor xenografts. ACS Appl Mater Interfaces 16(45):61787\u201361804. https:\/\/doi.org\/10.1021\/acsami.4c16609","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"5661_CR29","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/s0092-8674(00)80434-1","volume":"91","author":"P Li","year":"1997","unstructured":"Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X (1997) Cytochrome c and dATP-dependent formation of Apaf-1\/caspase-9 complex initiates an apoptotic protease cascade. Cell 91(4):479\u2013489. https:\/\/doi.org\/10.1016\/s0092-8674(00)80434-1","journal-title":"Cell"},{"issue":"17","key":"5661_CR30","doi-asserted-by":"publisher","first-page":"14735","DOI":"10.18632\/oncotarget.4023","volume":"6","author":"HY Lin","year":"2015","unstructured":"Lin HY, Glinsky GV, Mousa SA, Davis PJ (2015) Thyroid hormone and anti-apoptosis in tumor cells. Oncotarget 6(17):14735\u201314743. https:\/\/doi.org\/10.18632\/oncotarget.4023","journal-title":"Oncotarget"},{"key":"5661_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-10-95","volume":"10","author":"J Liu","year":"2011","unstructured":"Liu J, Uematsu H, Tsuchida N, Ikeda MA (2011) Essential role of caspase-8 in p53\/p73-dependent apoptosis induced by etoposide in head and neck carcinoma cells. Mol Cancer 10:95. https:\/\/doi.org\/10.1186\/1476-4598-10-95","journal-title":"Mol Cancer"},{"issue":"23","key":"5661_CR32","doi-asserted-by":"publisher","first-page":"5713","DOI":"10.3390\/molecules29235713","volume":"29","author":"W Liu","year":"2024","unstructured":"Liu W, Wu J, Jiang Z, Zhang X, Wang Z, Meng F, Liu Z, Zhang T (2024) Application of ordered porous silica materials in drug delivery: a review. Molecules (Basel, Switzerland) 29(23):5713. https:\/\/doi.org\/10.3390\/molecules29235713","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"4","key":"5661_CR33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, Calif.) 25(4):402\u2013408. https:\/\/doi.org\/10.1006\/meth.2001.1262","journal-title":"Methods (San Diego, Calif.)"},{"issue":"16","key":"5661_CR34","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1002\/smll.201000538","volume":"6","author":"J Lu","year":"2010","unstructured":"Lu J, Liong M, Li Z, Zink JI, Tamanoi F (2010) Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small 6(16):1794\u20131805. https:\/\/doi.org\/10.1002\/smll.201000538","journal-title":"Small"},{"issue":"11","key":"5661_CR35","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1021\/ar400122928","volume":"46","author":"D Manna","year":"2013","unstructured":"Manna D, Roy G, Mugesh G (2013) Antithyroid drugs and their analogues: synthesis, structure, and mechanism of action. Acc Chem Res 46(11):2706\u20132715. https:\/\/doi.org\/10.1021\/ar400122928","journal-title":"Acc Chem Res"},{"issue":"5","key":"5661_CR36","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.addr.2012.07.018","volume":"65","author":"V Mamaeva","year":"2013","unstructured":"Mamaeva V, Sahlgren C, Lind\u00e9n M (2013) Mesoporous silica nanoparticles in medicine\u2014Recent advances. Adv Drug Deliv Rev 65(5):689\u2013702. https:\/\/doi.org\/10.1016\/j.addr.2012.07.018","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"5661_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1021\/acs.molpharmaceut.7b00778","volume":"15","author":"CA McCarthy","year":"2018","unstructured":"McCarthy CA, Ahern RJ, Devine KJ, Crean AM (2018) Role of drug adsorption onto the silica surface in drug release from mesoporous silica systems. Mol Pharm 15(1):141\u2013149. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00778","journal-title":"Mol Pharm"},{"issue":"8","key":"5661_CR38","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nrc1893","volume":"6","author":"AI Minchinton","year":"2006","unstructured":"Minchinton AI, Tannock IF (2006) Drug penetration in solid tumours. Nat Rev Cancer 6(8):583\u2013592. https:\/\/doi.org\/10.1038\/nrc1893","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"5661_CR39","doi-asserted-by":"publisher","first-page":"R19","DOI":"10.1530\/ERC-12-0219","volume":"20","author":"LC Moeller","year":"2013","unstructured":"Moeller LC, F\u00fchrer D (2013) Thyroid hormone, thyroid hormone receptors, and cancer: a clinical perspective. Endocr Relat Cancer 20(2):R19\u2013R29. https:\/\/doi.org\/10.1530\/ERC-12-0219","journal-title":"Endocr Relat Cancer"},{"key":"5661_CR40","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1007\/s12633-022-02197-2","volume":"15","author":"B Mohammadi","year":"2023","unstructured":"Mohammadi B, Musavi Raziabadi S, Vessally E (2023) DFT study on the adsorption of propylthiouracil on Si- and Ga-doped carbon nanoflake and aluminum nitride nanosheets. SILICON 15:2693\u20132702. https:\/\/doi.org\/10.1007\/s12633-022-02197-2","journal-title":"SILICON"},{"issue":"1","key":"5661_CR41","first-page":"561","volume":"5","author":"VJ Mohanraj","year":"2006","unstructured":"Mohanraj VJ, Chen Y (2006) Nanoparticles\u2014a review. Trop J Pharm Res 5(1):561\u2013573","journal-title":"Trop J Pharm Res"},{"issue":"3","key":"5661_CR42","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1080\/02652040500100907","volume":"22","author":"WM Obeidat","year":"2005","unstructured":"Obeidat WM, Price JC (2005) Preparation and in vitro evaluation of propylthiouracil microspheres made of Eudragit RL 100 and cellulose acetate butyrate polymers using the emulsion-solvent evaporation method. J Microencapsul 22(3):281\u2013289. https:\/\/doi.org\/10.1080\/02652040500100907","journal-title":"J Microencapsul"},{"issue":"12","key":"5661_CR43","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nnano.2007.387","volume":"2","author":"D Peer","year":"2007","unstructured":"Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R (2007) Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol 2(12):751\u2013760. https:\/\/doi.org\/10.1038\/nnano.2007.387","journal-title":"Nat Nanotechnol"},{"key":"5661_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102340","volume":"62","author":"T Popova","year":"2021","unstructured":"Popova T, Tzankov B, Voycheva C, Spassova I, Kovacheva D, Tzankov S, Aluani D, Tzankova V, Lambov N (2021) Mesoporous silica MCM-41 and HMS as advanced drug delivery carriers for bicalutamide. J Drug Deliv Sci Technol 62:102340. https:\/\/doi.org\/10.1016\/j.jddst.2021.102340","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"5661_CR45","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, Doig A, Guilliams T, Latimer J, McNamee C, Norris A, Sanseau P, Cavalla D, Pirmohamed M (2019) Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov 18(1):41\u201358. https:\/\/doi.org\/10.1038\/nrd.2018.168","journal-title":"Nat Rev Drug Discov"},{"key":"5661_CR46","doi-asserted-by":"publisher","first-page":"22","DOI":"10.21037\/tbcr-23-32","volume":"4","author":"DR Radulski","year":"2023","unstructured":"Radulski DR, Stipp MC, Galindo CM, Acco A (2023) Features and applications of Ehrlich tumor model in cancer studies: a literature review. Transl Breast Cancer Res 4:22. https:\/\/doi.org\/10.21037\/tbcr-23-32","journal-title":"Transl Breast Cancer Res"},{"issue":"6382","key":"5661_CR47","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.aar4060","volume":"359","author":"A Ribas","year":"2018","unstructured":"Ribas A, Wolchok JD (2018) Cancer immunotherapy using checkpoint blockade. Science (New York, N.Y.) 359(6382):1350\u20131355. https:\/\/doi.org\/10.1126\/science.aar4060","journal-title":"Science (New York, N.Y.)"},{"issue":"3","key":"5661_CR48","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/annonc\/mdr275","volume":"23","author":"R Sabatier","year":"2012","unstructured":"Sabatier R, Eymard JC, Walz J, Deville JL, Narbonne H, Boher JM, Salem N, Marcy M, Brunelle S, Viens P, Bladou F, Gravis G (2012) Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma? Ann Oncol 23(3):714\u2013721. https:\/\/doi.org\/10.1093\/annonc\/mdr275","journal-title":"Ann Oncol"},{"issue":"2","key":"5661_CR49","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","volume":"169","author":"RA Saxton","year":"2017","unstructured":"Saxton RA, Sabatini DM (2017) mTOR signaling in growth, metabolism, and disease. Cell 169(2):361\u2013371. https:\/\/doi.org\/10.1016\/j.cell.2017.03.035","journal-title":"Cell"},{"issue":"3","key":"5661_CR50","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ccr.2006.08.015","volume":"10","author":"PT Schumacker","year":"2006","unstructured":"Schumacker PT (2006) Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell 10(3):175\u2013176. https:\/\/doi.org\/10.1016\/j.ccr.2006.08.015","journal-title":"Cancer Cell"},{"issue":"6230","key":"5661_CR51","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/science.aaa8172","volume":"348","author":"P Sharma","year":"2015","unstructured":"Sharma P, Allison JP (2015) The future of immune checkpoint therapy. Science (New York, N.Y.) 348(6230):56\u201361. https:\/\/doi.org\/10.1126\/science.aaa8172","journal-title":"Science (New York, N.Y.)"},{"issue":"11","key":"5661_CR52","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.addr.2008.03.012","volume":"60","author":"II Slowing","year":"2008","unstructured":"Slowing II, Vivero-Escoto JL, Wu CW, Lin VSY (2008) Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv Drug Deliv Rev 60(11):1278\u20131288. https:\/\/doi.org\/10.1016\/j.addr.2008.03.012","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"5661_CR53","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/08982100600992542","volume":"16","author":"W Suwakul","year":"2006","unstructured":"Suwakul W, Ongpipattanakul B, Vardhanabhuti N (2006) Preparation and characterization of propylthiouracil niosomes. J Liposome Res 16(4):391\u2013401. https:\/\/doi.org\/10.1080\/08982100600992542","journal-title":"J Liposome Res"},{"key":"5661_CR54","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.bios.2018.05.014","volume":"114","author":"Z Tahmasebi","year":"2018","unstructured":"Tahmasebi Z, Davarani SSH, Asgharinezhad AA (2018) Highly efficient electrochemical determination of propylthiouracil in urine samples after selective electromembrane extraction by copper nanoparticles-decorated hollow fibers. Biosens Bioelectron 114:66\u201371. https:\/\/doi.org\/10.1016\/j.bios.2018.05.014","journal-title":"Biosens Bioelectron"},{"issue":"2","key":"5661_CR55","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/00000441-200002000-00005","volume":"319","author":"C Theodossiou","year":"2000","unstructured":"Theodossiou C, Schwarzenberger P (2000) Propylthiouracil reduces xenograft tumor growth in an athymic nude mouse prostate cancer model. Am J Med Sci 319(2):96\u201399. https:\/\/doi.org\/10.1097\/00000441-200002000-00005","journal-title":"Am J Med Sci"},{"issue":"12","key":"5661_CR56","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/adma.201104763","volume":"24","author":"F Tang","year":"2012","unstructured":"Tang F, Li L, Chen D (2012) Mesoporous silica nanoparticles: Synthesis, biocompatibility and drug delivery. Adv Mater 24(12):1504\u20131534. https:\/\/doi.org\/10.1002\/adma.201104763","journal-title":"Adv Mater"},{"key":"5661_CR57","doi-asserted-by":"publisher","DOI":"10.1515\/pac-2014-1117","author":"M Thommes","year":"2015","unstructured":"Thommes M, Kaneko K, Neimark A, Sing KSW et al (2015) Physisorption of gases, with special reference to the evaluation of surface area and pore size distribution (IUPAC Technical Report). Pure Appl Chem. https:\/\/doi.org\/10.1515\/pac-2014-1117","journal-title":"Pure Appl Chem"},{"issue":"7","key":"5661_CR58","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrd2803","volume":"8","author":"D Trachootham","year":"2009","unstructured":"Trachootham D, Alexandre J, Huang P (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8(7):579\u2013591. https:\/\/doi.org\/10.1038\/nrd2803","journal-title":"Nat Rev Drug Discov"},{"issue":"4","key":"5661_CR59","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrm2147","volume":"8","author":"KH Vousden","year":"2007","unstructured":"Vousden KH, Lane DP (2007) p53 in health and disease. Nat Rev Mol Cell Biol 8(4):275\u2013283. https:\/\/doi.org\/10.1038\/nrm2147","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7","key":"5661_CR60","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1021\/cr068020s","volume":"107","author":"Y Wan","year":"2007","unstructured":"Wan Y, Zhao D (2007) On the controllable soft-templating approach to mesoporous silicates. Chem Rev 107(7):2821\u20132860. https:\/\/doi.org\/10.1021\/cr068020s","journal-title":"Chem Rev"},{"issue":"7","key":"5661_CR61","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3390\/nano7070189","volume":"7","author":"A Watermann","year":"2017","unstructured":"Watermann A, Brieger J (2017) Mesoporous silica nanoparticles as drug delivery vehicles in cancer. Nanomaterials (Basel, Switzerland) 7(7):189. https:\/\/doi.org\/10.3390\/nano7070189","journal-title":"Nanomaterials (Basel, Switzerland)"},{"key":"5661_CR62","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1021\/acs.cgd.0c01519","volume":"21","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Zhou L, Hao H, Bao Y, Yin Q, Xie C (2021) Cocrystals of propylthiouracil and nutraceuticals toward sustained-release: design, structure analysis, and solid-state characterization. Cryst Growth des 21:1202\u20131217. https:\/\/doi.org\/10.1021\/acs.cgd.0c01519","journal-title":"Cryst Growth des"},{"issue":"5","key":"5661_CR63","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/sj.clpt.6100400","volume":"83","author":"L Zhang","year":"2008","unstructured":"Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC (2008) Nanoparticles in medicine: therapeutic applications and developments. Clin Pharmacol Ther 83(5):761\u2013769. https:\/\/doi.org\/10.1038\/sj.clpt.6100400","journal-title":"Clin Pharmacol Ther"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05661-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05661-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05661-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:02:27Z","timestamp":1791579747000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05661-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,2]]},"references-count":63,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5661"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05661-7","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,2]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}